Endocyte (ECYT) Tops Q3 EPS by 6c

Endocyte (NASDAQ: ECYT) reported Q3 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Endocyte (ECYT) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance